Results 291 to 300 of about 783,580 (401)
ABSTRACT Aim Serum tumor markers are helpful for diagnosis, monitoring treatment outcomes, and prognosis. However, their clinical utility for esophageal squamous cell carcinoma (ESCC) and gastric cancer (GC) remains unclear. This study aimed to comprehensively evaluate recent studies on serum tumor markers in ESCC and GC.
Yasunori Matsumoto +2 more
wiley +1 more source
Dose-Response Relationship Between BRAF V600E Abundance and Cervical Lymph Node Metastasis in Papillary Thyroid Cancer. [PDF]
Yalikun Y +6 more
europepmc +1 more source
ABSTRACT Background Pancreatectomy for pancreatic ductal adenocarcinoma (PDAC) with arterial abutment is a complex, high‐risk surgery. We aimed to investigate the clinicopathological features, risk factors, and learning curve for local recurrence after pancreatectomy for PDAC with arterial abutment.
Jun Ishida +9 more
wiley +1 more source
Single-cell and spatial dissection of necroptosis spatiotemporal evolution driving lymph node metastasis in gastric cancer. [PDF]
Hu Y +9 more
europepmc +1 more source
ABSTRACT Background Nivolumab‐including chemotherapy (nivo‐CTX) for stage IV gastric cancer (GC) may increase the chance of conversion surgery but risk of immune‐related adverse events (irAEs) during perioperative period remains unclear. Methods We examined irAEs in 36 patients with marginally resectable GC who received nivo‐CTX followed by surgery ...
Masashi Nishino +11 more
wiley +1 more source
Case Report: Sebaceous lymphadenocarcinoma arising in parotid gland: eighth documented case with lymph node metastasis. [PDF]
Ru L, An F, Zou B.
europepmc +1 more source
A Case of Apocrine Carcinoma of the Eyelid with Parotid Gland Lymph Node Metastasis.
Chieko Yamada +4 more
openalex +2 more sources
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley +1 more source

